Free Trial

Patterson Companies (PDCO) Competitors

$23.98
+0.04 (+0.17%)
(As of 05/28/2024 ET)

PDCO vs. OMI, RXRX, MYGN, DCPH, GERN, ADMA, ASTH, VERA, KYMR, and AGL

Should you be buying Patterson Companies stock or one of its competitors? The main competitors of Patterson Companies include Owens & Minor (OMI), Recursion Pharmaceuticals (RXRX), Myriad Genetics (MYGN), Deciphera Pharmaceuticals (DCPH), Geron (GERN), ADMA Biologics (ADMA), Astrana Health (ASTH), Vera Therapeutics (VERA), Kymera Therapeutics (KYMR), and agilon health (AGL). These companies are all part of the "medical" sector.

Patterson Companies vs.

Patterson Companies (NASDAQ:PDCO) and Owens & Minor (NYSE:OMI) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, valuation, earnings, dividends, institutional ownership, media sentiment, risk and profitability.

Patterson Companies currently has a consensus price target of $31.67, indicating a potential upside of 32.28%. Owens & Minor has a consensus price target of $23.29, indicating a potential upside of 32.83%. Given Owens & Minor's higher possible upside, analysts clearly believe Owens & Minor is more favorable than Patterson Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Patterson Companies
0 Sell rating(s)
6 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.33
Owens & Minor
1 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Patterson Companies has a beta of 1.07, suggesting that its stock price is 7% more volatile than the S&P 500. Comparatively, Owens & Minor has a beta of 0.52, suggesting that its stock price is 48% less volatile than the S&P 500.

85.4% of Patterson Companies shares are held by institutional investors. Comparatively, 98.0% of Owens & Minor shares are held by institutional investors. 1.5% of Patterson Companies shares are held by insiders. Comparatively, 2.6% of Owens & Minor shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Patterson Companies had 12 more articles in the media than Owens & Minor. MarketBeat recorded 15 mentions for Patterson Companies and 3 mentions for Owens & Minor. Owens & Minor's average media sentiment score of 0.63 beat Patterson Companies' score of 0.09 indicating that Owens & Minor is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Patterson Companies
4 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
3 Negative mention(s)
1 Very Negative mention(s)
Neutral
Owens & Minor
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Patterson Companies has a net margin of 2.95% compared to Owens & Minor's net margin of -0.37%. Patterson Companies' return on equity of 20.98% beat Owens & Minor's return on equity.

Company Net Margins Return on Equity Return on Assets
Patterson Companies2.95% 20.98% 7.70%
Owens & Minor -0.37%12.97%2.26%

Patterson Companies received 111 more outperform votes than Owens & Minor when rated by MarketBeat users. Likewise, 52.47% of users gave Patterson Companies an outperform vote while only 48.54% of users gave Owens & Minor an outperform vote.

CompanyUnderperformOutperform
Patterson CompaniesOutperform Votes
361
52.47%
Underperform Votes
327
47.53%
Owens & MinorOutperform Votes
250
48.54%
Underperform Votes
265
51.46%

Patterson Companies has higher earnings, but lower revenue than Owens & Minor. Owens & Minor is trading at a lower price-to-earnings ratio than Patterson Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Patterson Companies$6.47B0.33$207.56M$2.0311.79
Owens & Minor$10.33B0.13-$41.30M-$0.51-34.37

Summary

Patterson Companies beats Owens & Minor on 13 of the 18 factors compared between the two stocks.

Get Patterson Companies News Delivered to You Automatically

Sign up to receive the latest news and ratings for PDCO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PDCO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PDCO vs. The Competition

MetricPatterson CompaniesMedical & hospital equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$2.14B$7.57B$5.00B$8.06B
Dividend Yield4.34%2.49%2.80%3.96%
P/E Ratio11.7917.90117.1114.02
Price / Sales0.331.142,571.7873.30
Price / Cash7.3110.7232.5528.79
Price / Book2.092.204.944.40
Net Income$207.56M$249.27M$103.73M$213.46M
7 Day Performance-3.51%-2.08%-1.01%-0.98%
1 Month Performance-7.10%-9.34%3.35%3.08%
1 Year Performance-9.66%-3.99%5.40%7.51%

Patterson Companies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OMI
Owens & Minor
4.5811 of 5 stars
$17.68
-1.8%
$23.29
+31.7%
-13.9%$1.35B$10.33B-34.6713,700
RXRX
Recursion Pharmaceuticals
1.7727 of 5 stars
$9.51
-2.8%
$12.75
+34.1%
+2.6%$2.23B$45.23M-5.94500
MYGN
Myriad Genetics
2.5423 of 5 stars
$24.38
-2.5%
$25.57
+4.9%
+3.9%$2.21B$753.20M-8.652,700
DCPH
Deciphera Pharmaceuticals
3.6805 of 5 stars
$25.47
flat
$24.17
-5.1%
+85.0%$2.20B$163.36M-11.52355Short Interest ↓
GERN
Geron
3.9549 of 5 stars
$3.70
-0.8%
$6.10
+64.9%
+7.1%$2.19B$240,000.00-10.57141Positive News
ADMA
ADMA Biologics
3.1064 of 5 stars
$9.60
+2.0%
$10.50
+9.4%
+134.3%$2.19B$258.21M-480.00624Positive News
ASTH
Astrana Health
2.3655 of 5 stars
$38.91
-0.4%
$46.33
+19.1%
N/A$2.18B$1.39B29.481,800Positive News
VERA
Vera Therapeutics
0.5917 of 5 stars
$39.76
-3.0%
$36.71
-7.7%
+387.6%$2.17BN/A-19.4051News Coverage
Gap Up
KYMR
Kymera Therapeutics
0.8882 of 5 stars
$35.32
-1.9%
$41.10
+16.4%
+15.7%$2.17B$78.59M-14.07186
AGL
agilon health
1.4186 of 5 stars
$5.55
+3.5%
$9.32
+68.0%
-69.9%$2.28B$4.87B-7.931,117

Related Companies and Tools

This page (NASDAQ:PDCO) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners